SpectraBase Spectrum ID |
8FzHJ1B4eFE |
Name |
Dormovit AC |
Classification |
Pharmaceutical drug derivative |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (3) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Barbituric acid derivatives |
DEA Controlled Substance Type |
Salts, isomers, derivatives and salts of isomers and derivatives |
DEA Controlled Substances Code Number |
2100 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
292.105921618 u |
Formula |
C14H16N2O5 |
InChI |
InChI=1S/C14H16N2O5/c1-8(2)14(7-10-5-4-6-21-10)11(18)15-13(20)16(9(3)17)12(14)19/h4-6,8H,7H2,1-3H3,(H,15,18,20) |
InChIKey |
LCHZHALIRRARLA-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
292.291 g/mol |
Nominal Mass |
292 u |
Quality |
989 |
Retention Index |
2296 |
SMILES |
C1(C(N(C(NC1=O)=O)C(=O)C)=O)(CC=1OC=CC1)C(C)C |
SPLASH |
splash10-0a4i-9170000000-bf57129ce9c006cce348 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
1-acetyl-5-(furan-2-ylmethyl)-5-(propan-2-yl)-1,3-diazinane-2,4,6-trione |
Technique |
GC/MS |
Wiley ID |
DD2024_001242 |